Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Davide Anchisi"'
Autor:
Davide Anchisi, Marco Zanon
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0117270 (2015)
The placebo effect is a component of any response to a treatment (effective or inert), but we still ignore why it exists. We propose that placebo analgesia is a facet of pain perception, others being the modulating effects of emotions, cognition and
Externí odkaz:
https://doaj.org/article/1fea4636d8b04b3fb65635d77be4b9e1
Publikováno v:
European Journal of Neuroscience. 12:2199-2204
Cerebellar Purkinje cells express both ionotropic glutamate receptors and metabotropic glutamate receptors. Brief tetanic stimulation of parallel fibers in rat and mouse cerebellar slices evokes a slow excitatory postsynaptic current in Purkinje cell
Autor:
Pietro, Cortelli, Daniela, Perani, Pasquale, Montagna, Roberto, Gallassi, Paolo, Tinuper, Federica, Provini, Provini, Federica, Patrizia, Avoni, Franco, Ferrillo, Davide, Anchisi, Rosa Maria, Moresco, Ferruccio, Fazio, Piero, Parchi, Agostino, Baruzzi, Elio, Lugaresi, Pierluigi, Gambetti
Publikováno v:
Brain
129 (2006): 668–675. doi:10.1093/brain/awl003
info:cnr-pdr/source/autori:Cortelli P. 3, Perani D. 1,2, Montagna P. 3, Gallassi R. 3, Tinuper P. 3, Federica P. 3, Avoni P. 3, Ferrillo F. 4, Anchisi D. 1, Moresco R.M, 2. Fazio F. 2, Parchi P. 3, Baruzzi A. 3, Lugaresi E. 3, Gambetti P. 5/titolo:Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies/doi:10.1093%2Fbrain%2Fawl003/rivista:Brain (Print)/anno:2006/pagina_da:668/pagina_a:675/intervallo_pagine:668–675/volume:129
129 (2006): 668–675. doi:10.1093/brain/awl003
info:cnr-pdr/source/autori:Cortelli P. 3, Perani D. 1,2, Montagna P. 3, Gallassi R. 3, Tinuper P. 3, Federica P. 3, Avoni P. 3, Ferrillo F. 4, Anchisi D. 1, Moresco R.M, 2. Fazio F. 2, Parchi P. 3, Baruzzi A. 3, Lugaresi E. 3, Gambetti P. 5/titolo:Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies/doi:10.1093%2Fbrain%2Fawl003/rivista:Brain (Print)/anno:2006/pagina_da:668/pagina_a:675/intervallo_pagine:668–675/volume:129
Knowing how and when the degenerative process starts is important in neurodegenerative diseases. We have addressed this issue in fatal familial insomnia (FFI) measuring the cerebral metabolic rate of glucose (CMRglc) with 2-[18F]fluoro-2-deoxy-D-gluc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f883e789f7a060431be2f19913261737
http://hdl.handle.net/11390/850911
http://hdl.handle.net/11390/850911
Publikováno v:
Scopus-Elsevier
Tempia, Filippo, Maria Concetta Miniaci, Davide Anchisi, and Piergiorgio Strata. Postsynaptic current mediated by metabotropic glutamate receptors in cerebellar Purkinje cells. J. Neurophysiol. 80: 520–528, 1998. In rat cerebellar slices, repetitiv
Autor:
Davide Anchisi, Luana Colloca, Fabrizio Benedetti, Carlo Adolfo Porro, Fausta Lui, Davide Duzzi
Despite growing interest in the placebo effect, the neural correlates of conditioned analgesia are still incompletely understood. We investigated herein on brain activity during the conditioning and post-conditioning phases of a placebo experimental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::259ccbbb7fc755a27a831db8011d1289
http://hdl.handle.net/11390/866873
http://hdl.handle.net/11390/866873
Autor:
Barbara Paghera, Alessandro Padovani, Antonella Alberici, Davide Anchisi, Daniela Perani, Barbara Borroni, Silvana Archetti, Chiara Agosti, M. Di Luca
Objective – The modulating factors on phenotypic expression of frontotemporal lobar degeneration (FTLD) remain still unknown. The aim of this study was to determine whether tau genetic variability modulates the brain functional and the clinical phe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e66d2552cce357ca528a4b5665d13b1c
http://hdl.handle.net/11390/856949
http://hdl.handle.net/11390/856949
A Bayesian Perspective on Sensory and Cognitive Integration in Pain Perception and Placebo Analgesia
Autor:
Marco Zanon, Davide Anchisi
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 2, p e0117270 (2015)
PLoS ONE, Vol 10, Iss 2, p e0117270 (2015)
The placebo effect is a component of any response to a treatment (effective or inert), but we still ignore why it exists. We propose that placebo analgesia is a facet of pain perception, others being the modulating effects of emotions, cognition and
Autor:
Daniela Perani, Alessandro Padovani, Barbara Borroni, Nacer Kerrouche, M. Di Luca, B. Vicini, Luigi A. Vignolo, Davide Anchisi, Barbara Paghera, Valentina Garibotto, Raffaele Giubbini, A. Terzi
Identifying pre-clinical Alzheimer's disease (AD) in subjects with mild cognitive impairment (MCI) is a major issue in clinical diagnosis. Establishing a combination of predictive markers from different fields of research might help in increasing the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a75e12344e9f183030065ebc8c8b486f
http://hdl.handle.net/11379/28983
http://hdl.handle.net/11379/28983
Autor:
Vjera Holthoff, Oriana Pelati, Rüdiger Mielke, Karl Herholz, Davide Anchisi, Daniela Perani, Paola Ortelli, Sandro Sorbi, Elio Scarpini, Alessandra Marcone, Massimo Franceschi, Stephan Ludecke, Barbara Borroni, Alberto Pupi, Alessandro Padovani, Olaf Lenz, Erik Salmon, Simon Weisenbach, Elke Kalbe, Stephano Cappa, Bettina Beuthien-Beumann, F. Fazio, Nasser Kerrouche
Publikováno v:
Archives of Neurology 62(2005)11, 1728-1733
Archives of neurology (Chic.) 62 (2005): 1728–1733.
info:cnr-pdr/source/autori:Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, Cappa S, Lenz O, Ludecke S, Marconi A, Mielke R, Ortelli P, Padovani A, Pelati O, Pupi A, Scarpini E, Weisenbach S, Herholz K, Salmon E, Holthoff V, Sorbi S, Fazio F, Perani D./titolo:Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease./doi:/rivista:Archives of neurology (Chic.)/anno:2005/pagina_da:1728/pagina_a:1733/intervallo_pagine:1728–1733/volume:62
Archives of neurology (Chic.) 62 (2005): 1728–1733.
info:cnr-pdr/source/autori:Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, Cappa S, Lenz O, Ludecke S, Marconi A, Mielke R, Ortelli P, Padovani A, Pelati O, Pupi A, Scarpini E, Weisenbach S, Herholz K, Salmon E, Holthoff V, Sorbi S, Fazio F, Perani D./titolo:Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease./doi:/rivista:Archives of neurology (Chic.)/anno:2005/pagina_da:1728/pagina_a:1733/intervallo_pagine:1728–1733/volume:62
Background Subjects with amnesic mild cognitive impairment (aMCI) may include patients at high risk for progression to Alzheimer disease (AD) and a population with different underlying pathologic conditions. Objective To evaluate the potential roles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81771c97785c439e0b06c998096fa6c9
http://hdl.handle.net/10281/26392
http://hdl.handle.net/10281/26392